“Everyone should have Lp(a) measured once in their adult life. It is not an expensive test, and it could make a huge difference in how you approach your health.” — Bradley Bush, ND
Normal LDL doesn’t always mean low heart risk. Lipoprotein(a), or Lp(a), is a largely genetic risk marker linked to blood clots, stroke, heart attack, and arterial calcification. Most people have never been tested for it. In this episode, Rob Lutz talks with Bradley Bush, ND, about why every adult should have Lp(a) measured at least once, and how the result can change treatment decisions.
In this episode, you’ll learn:
- Why Lp(a) is largely genetic and how it raises clotting risk
- How extended-release, wax-matrix niacin improves tolerance compared with older products
- Practical niacin titration and monitoring tips, including liver enzyme checks
- How niacin may lower Lp(a) by 20% to 30% in some patients
- How nattokinase supports fibrinolysis, circulation, and blood flow
- How to use these tools in a personalized cardiometabolic strategy
Key Moments:
10:54 – Lp(a): the genetic factor and clotting risk
17:58 – Extended-release niacin and managing flushing
32:16 – Nattokinase, blood flow, and fibrin reduction
LISTEN NOW
About Dr. Bradley Bush, ND
Dr. Bush is a recognized leader in naturopathic medicine, an innovator of advanced formulations, and a trusted consultant to the natural products industry. He earned his naturopathic degree from the National College of Naturopathic Medicine. He is owner and Clinic Director of Natural Medicine of Stillwater and founder of Neurovanna Lab. His practice focuses on chronic disease, fatigue, insomnia, mood, gastrointestinal, and post-infectious disorders, using conventional and alternative testing to uncover root causes.
Related Content:
- Is Niacin Still an Effective Option for Lipid Management?
- Why Niacin Remains Unique for Lipid and Lp(a) Support
- Is Nattokinase Underdosed? What a Large Patient Study Found
- Understanding Lipoprotein(a)
